SLC36A4 and colorectal cancer: By using an inducible PAT4 shRNA knockdown in HCT116 colorectal cancer cells, we find that PAT4 responds to two rapidly metabolised, non-essential amino acids, glutamine and serine,26, 27 to drive rapamycin-resistant, mTORC1-mediated cell proliferation.